Pfizer’s Torisel drug fails in a combination study – Reuters

by Blogburger on August 13, 2012


CNBC.com
Pfizer's Torisel drug fails in a combination study
Reuters
(Reuters) – Pfizer Inc said on Friday that a late-stage trial of its drug for renal cell cancer failed to meet its main goal when given in combination with Avastin, a drug made by Roche Holding AG. Pfizer's drug Torisel is approved as a single agent
Reuters Health News SummaryChicago Tribune
Pfizer: Phase 3 Trial of Torisel for RCC Patients Fails to Meet Primary EndpointWall Street Journal
Pfizer says Torisel-Avastin failed in cancer studyCBS News
FierceBiotech -RTT News
all 71 news articles »

Health – Google News

by Amazon Auto Links

Comments on this entry are closed.

Previous post:

Next post: